[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
TacticzHazel - Value Investing has been discussing and sharing insights on various stocks, with a focus on long-term holds and undervalued companies. The conversation revolves around sharing favorite stocks, portfolio compositions, and buy levels, with some users expressing bullish sentiments on $nbis, $asml, $googl, and $tsm. Discussions also center around the potential for certain stocks to grow or be undervalued, with $nbis and $asml being mentioned as having significant potential.
Social category influence finance #1145 stocks #1331 technology brands #7284 countries XXXX% cryptocurrencies #4690 automotive brands #2938 luxury brands XXXX% fashion brands XXXX% travel destinations XXXX% currencies XXXX%
Social topic influence $nvo #3, $asml #13, asml #27, $nbis #45, $dlo #4, $tsm #19, $lly #48, $meli #45, $se #1, investment #71
Top accounts mentioned or mentioned by @meeijer @mmoney642 @gainifyio @longoption @simeonresearch @wealthmatica @bourboncap @dividendg_web3 @qualityinvest5 @sojustfollowme @investingvisual @yodastockinvest @richardwedekin1 @finfluentialx @qualitystocksa @deepicevalue @thexcapitalist @gabgrowth @realroseceline @heyflorent
Top assets mentioned Novo-Nordisk (NVO) Nebius Group N.V. Class A Ordinary Shares (NBIS) DLocal Limited Class A Common Shares (DLO) Taiwan Semiconductor (TSM) Eli Lilly and Company (LLY) MercadoLibre Inc (MELI) Sea Limited (SE) NVIDIA Corp. (NVDA) IREN Limited (IREN) Alibaba Group (BABA) Advanced Micro Devices (AMD) S&P Global Inc (SPGI) Ferrari N.V. (RACE) NuCypher (NU) Spotify Technology (SPOT) Oscar Health, Inc. (OSCR) Robinhood Markets, Inc. (HOOD) Grab Holdings Limited Class A Ordinary Shares (GRAB) Fair Isaac, Corp. (FICO) Hims & Hers Health, Inc. (HIMS) UnitedHealth Group (UNH) Nu Holdings Ltd. (NU) RAI Finance (SOFI) Axon Enterprise, Inc. (AXON) Microsoft Corp. (MSFT) AST SpaceMobile, Inc. Class A Common Stock (ASTS) Builders FirstSource, Inc. (BLDR) Merit Circle (MC) Vistra, Corp. (VST) Tesla, Inc. (TSLA) Enphase Energy Inc (ENPH) Amazon.com, Inc. (AMZN) Oklo Inc. (OKLO) Duolingo, Inc. Class A Common Stock (DUOL) Mastercard, Inc. (MA) Moody's Corporation (MCO) Costco Hot Dog (COST) Akropolis (AKRO) Coupang, Inc. (CPNG) Palantir (PLTR) CoreWeave, Inc. (CRWV) The Root Network (ROOT) Intel Corporation (INTC) Costco Wholesale Corporation (COST) Waste Management, Inc. (WM) Huntington Ingalls Industries Inc (HII) Intuit Inc. (INTU) Nike Inc (NKE) Cream (CRM) ZetaChain (ZETA) Marvell Technology Inc (MRVL) Cipher Mining Inc. Common Stock (CIFR)
Top posts by engagements in the last XX hours
"7/ Obesity Market + TAM The global weight-loss market is projected to hit over $150B by 2030. The growth of the sector is undeniable and maybe even underestimated. To add to this the total market still remains quite untapped as most of the obese and overweight people are not receiving any treatment yet. Novo currently only covers about XXX% of the total TAM. But the big question remains who will take what percentage of the market I think Novo is in a great spot to take a large part of this market. Maybe not the LARGEST but they dont have to be to still show significant growth in the upcoming"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 1444 engagements
"@HatedMoats Nice list $ZTS is a cool one I forgot about them"
X Link @TacticzH 2025-10-10T21:19Z 28.2K followers, XXX engagements
"4/ $ENPH Enphase is down XX% YTD but a whopping XX% from it's ATH. High interest rates are making it more expensive for homeowners to finance solar installations which has led to a significant drop in residential solar demand. They are also facing operational challenges; overstocked inventory that is putting pressure on margins and new tariffs on solar components from China. Management is taking steps to cut costs and shift manufacturing. But investors are not impressed. Especially since Enphase missed recent earnings estimates and provided a weak outlook. Enphase is so incredibly out of"
X Link @TacticzH 2025-07-31T15:02Z 28.2K followers, 7762 engagements
"5/ $AXON Axon Enterprise $AXON stock has jumped just over XX% after another earnings beat. They have beat earnings every quarter for the last two years. What did investors like Quarterly revenue is up XX% EPS Beat + Guidance raised Added multiple large (international) contracts NRR grew from XXX% to XXX% Would I buy into $AXON right now While I absolutely love $AXON I think it's just too expensive right now. It's moat it's growth it's leadership and it's TAM are making me incredibly bullish but the valuation is just something else. Priced for perfection. I will re-open (cause I recently sold)"
X Link @TacticzH 2025-08-08T13:08Z 28.1K followers, 17.9K engagements
"5.2/ Competition - Others Other noteworthy competitors are: Roche $ROG Roche is also making a push into the obesity market with a new strategy focused on building a diverse portfolio rather than relying on a single drug. Theyve made a couple of key acquisitions in the past year including the purchase of Carmot Therapeutics for its lead GLP-1/GIP drug and a partnership with Zealand Pharma for Petrelintide an amylin analog. Sanofi $SAN Sanofis strategy in the obesity sector is to avoid the GLP-1 drug race with Novo Nordisk and Eli Lilly. Instead Sanofi is aiming at more innovative"
X Link @TacticzH 2025-10-03T14:46Z 28.3K followers, 1526 engagements
"10.3/ Margins While steadily growing and taking advantage of the obesity pandemic Novo has always maintained very high margins. - Gross margin: XXXX% - Net profit margin: XXXX% - FCF Margin: XXXX% Albeit still very high margins are slightly under pressure lately. This is due to the forementioned capex spend and higher R&D spending to keep up with the competition. Margins will also face pressure do to the restructuring that will take place in H2-25"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 1145 engagements
"@GabGrowth $SPGI 😆"
X Link @TacticzH 2025-10-09T09:58Z 28.3K followers, XXX engagements
"$NVO - HSBC has upgraded Novo Nordisk from "HOLD" to "BUY". Main reasons for the upgrade: - More focus on reimbursed medical and DTC-channels - Pipeline deserves more recognition - Data readouts for REDEFINE4 which is examining CagriSema against Lilly's weight loss drug Zepbound (tirzepatide) and the EVOKE trial testing oral semaglutide (the active ingredient in Wegovy) for Alzheimer's disease could provide a nice risk/reward I can't find a specific price target. I see claims on X that it went from $XX tot $XX but I don't see it confirmed by HSBC. I think people are misinterpreting the $70"
X Link @TacticzH 2025-10-02T07:46Z 28K followers, 20.2K engagements
"@meeijer Nice thread Datacenters are the new gold it seems. You compiled a great list. Out of these $NBIS $ASML and $TSM are my favourites"
X Link @TacticzH 2025-10-05T20:41Z 28.2K followers, 2821 engagements
"@HatedMoats This is bad news indeed. Will check it out tomorrow Do you have a source"
X Link @TacticzH 2025-10-13T20:58Z 28.2K followers, 1301 engagements
"I think you are absolutely right here. It deserves a premium due to it's strong brand and predictability. But such low CAGR growth simply limits returns. Rerating seems reasonable. Gonna take a closer look to as I've been wanting to get in $RACE for a long time. It's just not clear to me if this actually changes the whole thesis"
X Link @TacticzH 2025-10-09T12:28Z 28.2K followers, 1096 engagements
"@tosti____ You sold $NVO 🤣"
X Link @TacticzH 2025-10-09T16:07Z 28.3K followers, XXX engagements
"Is $AMZN the clearest buy in the market today"
X Link @TacticzH 2025-10-14T14:21Z 28.3K followers, 91.4K engagements
"I found EIGHT companies where the stock price is severely lagging its fundamentals. All of them are out of favor right now. Most of them unloved. 💔 A momentum shift could lead to significant upside. The question is do you believe in their stories 🧵 1/ 3/ $DLO DLocal Since IPO Revenue: +1307% EPS: +787% Stock price: -XX% $DLO is one of my favorite companies right now and I've recently taken a position. The hold a strong position in the emerging market payment solutions sector and have been increasing their TPV incredibly fast. Can they keep their take rate under control and will they fight"
X Link @TacticzH 2025-07-09T20:29Z 28.2K followers, 45K engagements
"@OK_Surf You're welcome :D"
X Link @TacticzH 2025-10-13T11:24Z 28.1K followers, XXX engagements
"🚨Portfolio Update September - XX% YTD🚨 Just posted my portfolio update for the month September. I'm up XX% vs XXXX% for the S&P500. I cover: ✅My performance (also vs benchmarks) ✅Sentiment for my holdings ✅Plans + update for all my holdings ✅My watchlist I post all my buys and sells when I do them and provide you with a monthly portfolio update. No paywall. 📎 Link in my bio"
X Link @TacticzH 2025-10-01T13:27Z 27.9K followers, 20.3K engagements
"4.2 /Pipeline In my opinion these are the X most promising drugs still in the pipeline (besides Oral Wegovy) - Cagrisema: CagriSema is a combination therapy that pairs Semaglutide with Cagrilintide a long-acting amylin analogue. -Amycretin: Amycretin combines the GLP-1 and Amylin receptor agonism into a single molecule. This dual mechanism aims to enhance appetite suppression and metabolic regulation. - UBT251: UBT251 is an experimental triple receptor agonist developed by The United Laboratories targeting GLP-1 GIP and glucagon receptors. Novo Nordisk secured global licensing rights for"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 2010 engagements
"5.1 / Competition Eli Lilly First lets address the elephant in the room: Eli Lilly. $LLY is by far the largest competitor to Novo Nordisk. Novo and Lilly have both bet heavily on the diabetes and obesity sector with their GLP-1s making the current market a duopoly. Unlike Novo Nordisk Eli Lilly has a more diversified portfolio with about XX% of the company aimed at diabetes and obesity. Their two most noteworthy drugs in the obesity segment are: - Mounjaro ( diabetes) - Zepbound ( obesity) Both are based around the GLP-1 agonist Tirzepatide. Lets compare them to Novos Ozempic and Wegovy. To"
X Link @TacticzH 2025-10-03T14:46Z 28.3K followers, 1766 engagements
"Is this a bubble or the beginning of a new Era Whichever way you put it. OpenAI and $NVDA are in the middle of it all"
X Link @TacticzH 2025-10-10T06:09Z 28.3K followers, 7376 engagements
"So now it's Biden's stock market again right"
X Link @TacticzH 2025-10-10T21:30Z 28.2K followers, 11.1K engagements
"@TheBrilliantBu1 Ye I've been hearing and seeing a lot about $ROOT lately. Haven't gotten around to giving it a proper look. Have a good deep dive somewhere"
X Link @TacticzH 2025-10-13T20:20Z 28.2K followers, 2547 engagements
"12 Non-US Companies to consider as a long-term investor: - $ASML ASML - $CSU Constellation Software - $MELI Mercadolibre - $NU Nu Holdings - $RACE Ferrari - $SPOT Spotify - $ADYEN Adyen - $PME Pro Medicus - $RMS Hermes - $EVO Evolution AB - $TSM Taiwan Semiconductor - $CDLR Cadeler Which would you add"
X Link @TacticzH 2025-06-01T15:42Z 28.2K followers, 39K engagements
"$ASML - Why ASML is up XX% in the last month Some of the gains are because of rerating due to undervaluation but several other factors might be: Increasing CAPEX spend on datacenter/AI infrastructure. More GPU demand -- $NVDA -- $TSM -- $ASML $TSM has been performing incredibly well SK Hynix dabbling into HIGH-NA EUV $INTC receiving backing from $NVDA and increased support from the US AI-driven growth in the memory-chip market -- SK Hynix and Samsung are ramping up production Forecasts of sales increase across smartphones and PCs Less relevant: but some price targets were updates this month"
X Link @TacticzH 2025-10-02T10:59Z 27.9K followers, 19.7K engagements
"These are the current Fintwit Favorites. Which one has the most potential from this point - $NBIS Nebius - $OSCR Oscar Health - $DUOL Duolingo - $GRAB Grab - $IREN Iren ltd - $FOUR Shift4 Payments - $ROOT Root inc - $LMND Lemonade - $OPEN Opendoor - $BMNR Bitmine Immersion Technologies - $SOFI Sofi - $HOOD Robinhood - $OKLO Oklo - $IONQ IONQ"
X Link @TacticzH 2025-09-21T19:39Z 28.2K followers, 75.5K engagements
"My top XX of companies with the strongest MOATs X. $ASML - ASML X. $FICO - Fair Isaac Corp X. $SPGI - S&P Global X. $MCO - Moody's Corp X. $V / $MA - Visa and Mastercard X. $EVO- Evolution Ab X. $MSFT - Microsoft X. $TSM - Taiwan Semiconductor Manufacturing X. $HII - Huntington Ingalls XX. $COST - Costco XX. $WM - Waste Management XX. $TSCO - Tractor Supply Company XX. $EFX - Equifax XX. $SAP - SAP XX. $ICE - Intercontinental Exchange XX. $GGG - Graco XX. $INTU - Intuit XX. $ORLY - O'Reilly Auto Parts XX. $UNP - Union Pacific XX. $KO - Coca Cola Do you agree with this list Which would you add"
X Link @TacticzH 2025-09-04T12:39Z 28.3K followers, 64.9K engagements
"6/ $FFX Fairfax Financial Holdings Fairfax Financial Holdings is a Canadian financial holding company based in Toronto. They have holdings in property casualty insurance and reinsurance investment management and insurance claims management Fairfax Financial earns money through its insurance and reinsurance businesses by collecting premiums and targeting underwriting profits. It invests the float from these operations across stocks bonds and private equity to generate additional returns. The company is known for its disciplined value-oriented investment strategy under their CEO Prem Watsa."
X Link @TacticzH 2025-07-14T20:24Z 28K followers, 9891 engagements
"If you think $NBIS is overvalued because it has a high PE you should stick to investing in ETFs"
X Link @TacticzH 2025-10-04T07:34Z 28.2K followers, 39.7K engagements
"It's just a matter of time before $NVO will have it's $BABA moment. Purely on PE/Multiple expansion you can easily get a XX% return before the end of 2026. Avg fwd PE last X year: XXXXX Avg fwd PE since 2016: XXXXX Current fwd PE: XXXXX Why would this not work from here"
X Link @TacticzH 2025-10-06T09:43Z 28.2K followers, 28.8K engagements
"My XX favorite non-US companies Ranked on buy-worthiness right now: - $NVO Novo Nordisk - $ASML ASML - $EVO Evolution AB - $BABA Alibaba - $DLO Dlocal - $CSU Constellation Software - $MELI MercadoLibre - $TSM Taiwan Semiconductor - $SE Sea Ltd - $NBIS Nebius Do you agree and which companies would you add Sidenote: I think they are all quite reasonably valued right now"
X Link @TacticzH 2025-08-18T11:09Z 28.3K followers, 85.8K engagements
"20 Companies with huge MOATS. What would your top X look like $ASML - ASML Holding NV $KO - Coca Cola $COST - Costco $CPRT - Copart $CSX - CSX Corp / $UNP - Union Pacific Corp $EVO - Evolution AB $FICO - Fair Isaac Corp $GGG - Graco Inc $HII - Huntington Ingalls Industries Inc $ICE - Intercontinental Exchange Inc $INTU - Intuit $MA - Mastercard / $V - Visa $MCO - Moody's Corp / $SPGI - S&P Global $MSFT - Microsoft $TSM - Taiwan Semiconductor Manufacturing $TSCO - Tractor Supply Co $WM - Waste Management Any companies I missed"
X Link @TacticzH 2025-04-24T11:38Z 28.2K followers, 2764 engagements
"ROAST MY PORTFOLIO DO NOT HOLD BACK What would you change/add/remove"
X Link @TacticzH 2025-06-08T20:31Z 28.2K followers, 73.1K engagements
"🪐My current investable Universe 🪐 Any suggestions for stocks to add to this universe $AMZN ✅ $AMD 🟠 $ASML ✅ $ASTS $AXON ✅ $BABA ✅ $BLDR ✅ $CDLR $COST $CRM $CSU $EVO ✅ $FICO $GOOG ✅ $GRAB $HIMS 🟠 $HOOD $KKR $LLY $MC ✅ $MCO $META $MSFT ✅ $NBIS ✅ $NFLX $NKE $NU $NVDA ✅ $NVO ✅ $OSCR 🟠 $PEP $PLTR $PME $RACE 🟠 $SOFI $SPOT 🟠 $SPGI ✅ $TSLA $TSM ✅ $UBER $V ✅ $VST ✅ How many do you own ✅ = I own 🟠= High on watchlist but want better price"
X Link @TacticzH 2025-06-04T14:11Z 28.2K followers, 22.3K engagements
"@meeijer Fully agree. Just a matter of time before it will have it's $UNH moment"
X Link @TacticzH 2025-10-14T18:15Z 28.2K followers, 1468 engagements
"$NVO's CEO Doustdar on the $AKRO acquisition: "MASH destroys lives silently - and efruxifermin (EFX) has the potential to change that by reversing liver damage" "If approved we believe it could become a CORNERSTONE therapy alone or together with Wegovy to tackle one of the fastest-growing metabolic diseases of our time.''"
X Link @TacticzH 2025-10-09T11:24Z 28.2K followers, 7947 engagements
"$ASML is giving up some of it gains in early morning trading in Europe likely in sympathy with $ASMI $ASMI also a Dutch semiconductor business (equipment) lowered their H2 revenue goals. Could also just be a bit of daily volatility"
X Link @TacticzH 2025-09-23T07:39Z 27.9K followers, 5321 engagements
"Last words and my plan Even though this is a long thread my full deep dive is even more extensive. You can find it here: If you've already read it thank you. And you should probably ignore this thread haha. Closing words $NVO is currently one of my highest conviction plays as I really like the risk/reward it gives due to its attractive valuation. I have been scaling into the position since March this year and currently have a cost basis of $XXXXX. My latest add was this week at a price of $XXXXX. For now I am happy with the current position which is about X% of my portfolio. If the share"
X Link @TacticzH 2025-10-03T14:47Z 28.2K followers, 3390 engagements
"$NVO $LLY India is a key market for Eli Lilly Eli Lilly will invest more than $1B in India in the coming years to boost manufacturing and supply through local drugmakers India is projected to have the world's second largest obesity population in 2050. Still a long way out but significant nonetheless"
X Link @TacticzH 2025-10-06T09:56Z 28.1K followers, 10.2K engagements
"US markets are closed today. Here are a couple of (lesser-known) companies to research during this boring day: $ZETA Zeta Global Holdings $IREN Iren $CDNS Cadence Design Systems $SNPS Synopsys $MRVL Marvell $SE Sea Ltd $CPNG Coupang $FRFHF Fairfax Financial $PME Pro Medicus $BLDR Builders Firstsource $NU Nu Holdings $CDLR Cadeler $AXON Axon $KPG Kelly Partners $EFX Equifax $GAMB Gambling (.com) Group $BULL Webull corp Which has the most potential you think Any other companies worth researching"
X Link @TacticzH 2025-07-04T06:10Z 28K followers, 20K engagements
"🚨Just in - $NVO to acquire Akero Therapeutics🚨 This further enhances Novo's portfolio for the treatment of MASH. Akero's Efruxifermin (EFX) is the only treatment that shows significant fibrosis regression in phase X in patients with compensated Cirrhosis. EFX is currently in phase X development for the treatment of patients with advanded liver fibrosis. They will acquire Akero for $XX per share (current price was $XXXXX - so that's about a XX% premium) Shares are are down about X% on the news"
X Link @TacticzH 2025-10-09T10:13Z 28.2K followers, 35.9K engagements
"@KairosPraxis Sorry I don't really follow what you're saying"
X Link @TacticzH 2025-10-10T21:19Z 27.9K followers, XXX engagements
"$NVO - Novo Nordisk Deep Dive is live I have just posted my deep dive on Novo Nordisk. It's my first big deep dive into the company. I had a lot of fun writing this. I look forward to your feedback comments and if you liked it your support Any like share comment or follow truly helps me out. I still think I've only grasped a small part of the company and have a lot more to learn. But it's a decent start for anyone interested in Novo Nordisk 📎Link in my bio and in the comment section Next deep dive will very likely be on $ASML"
X Link @TacticzH 2025-09-30T18:11Z 28K followers, 46.3K engagements
"🚨 $ASML Q3 Earnings are out 🚨 - Rev: 7.5B vs est: 7.65B 🔴 - EPS XXXX vs est XXXX 🟢 - Net bookings: 5.4B vs est 5.2B 🟢 Outlook Q4 Rev: 9.2-9.8B - consensus was 9.3B 🟢 Gross margin: 51-53% - consensus XXX% 🟢 Important Outlook for 2026: $ASML does not expect 2026 total net sales to be below 2025. FY guidance 2026 will be given in January Dividend of XXX will be made payable in november. A new buyback program will be released in January. The 2025 program will likely not be finalized. Highlights from the CEO statement: - On the technology side we see litho intensity continue to develop"
X Link @TacticzH 2025-10-15T05:19Z 28.2K followers, XXX engagements
"@InvestingVisual I lean towards $SPOT. Both great companies though. But would love better valuations for both"
X Link @TacticzH 2025-10-08T19:57Z 28.1K followers, XXX engagements
"7/ $VST Vistra Corp Vistra is a leading integrated power producer and retailer with a diverse portfolio of natural gas nuclear and renewable plants. It generates electricity for wholesale markets and retail customers providing reliable and affordable energy. The AI data center boom is driving huge power demand creating a structural tailwind for Vistra. Its reliable baseload generation makes it a top partner for long-term power deals with tech giants. By co-locating data centers near its plants Vistra cuts transmission costs and locks in recurring revenue fueling strong earnings growth in the"
X Link @TacticzH 2025-09-09T17:27Z 28.2K followers, 7541 engagements
"@meeijer Nice list My favourites are $TSM $ASML and $NBIS"
X Link @TacticzH 2025-10-11T20:31Z 28.2K followers, 2355 engagements
"@DeepIceValue Won't do XXX% like some of these other companies no. But could be a nice solid holding for the next decade imo"
X Link @TacticzH 2025-10-14T15:05Z 28.2K followers, 3278 engagements
"2.2/ Company Overview Novo Nordisk currently employs just over 77000 people worldwide. They have employees in XX countries and market their products in XXX countries. Novo Nordisk nearly doubled its employee count in the last decade: from 41122 in 2015 to 77349 in 2024. They recently announced that they are going to cut 9000 roles. While cutting jobs is never a fun thing to do sometimes it is the right decision. This decision resulted in a lower operating profit guidance for 2025 as they need to pay coverage-packages and finance the restructuring processes. The first cut was already announced"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 2162 engagements
"$DLO jumped X% as the U.S. has completed a $20B currency swap deal with Argentina and is also buying Argentine pesos directly to help support and stabilize Argentinas economy. Other companies with exposure to Lat- am (like $MELI) also rise as this is a clear signal of the US backing and supporting the Argentian economy"
X Link @TacticzH 2025-10-09T20:08Z 28.3K followers, 22K engagements
"9/ $MOD Modine Manufacturing Modine is a global leader in thermal management with a fast-growing Data Center Cooling segment that delivers advanced systems including liquid cooling for AI and HPC facilities. The AI creates surging demand for efficient cooling as traditional air systems cant handle the heat output of modern GPUs. Modines expertise in liquid cooling makes it a key enabler of this transition. To meet demand it is expanding production capacity in North America positioning itself as a critical picks-and-shovels supplier to the MAG7s data center buildout"
X Link @TacticzH 2025-09-09T17:27Z 27.9K followers, 6315 engagements
"Why I think: $HOOD is not a buy right now $SOFI is not a buy right now $PLTR is not a buy right now $TSLA is not a buy right now $CRWV is not a buy right now $NBIS is not a buy right now $IREN is not a buy right now While it is crystal clear that some of these are poised to do really well in the future I think the risk/reward is not in your favor right now. And that goes for a lot of other growth names as well. Not even X months ago the odds were a lot better. While fundamentals have changed for the better for most of these names after some of the run-ups we've seen major pullbacks are"
X Link @TacticzH 2025-09-20T08:44Z 28.2K followers, 383.8K engagements
"The Ultimate $1.000.000 AI Data-center Portfolio $XXXXXXX $ASML ASML $XXXXXXX $TSM Taiwan Semi $XXXXXXX $NVDA Nvidia $XXXXXX $AMD Advanced Micro Devices $XXXXXX $NBIS Nebius $XXXXXX $IREN Iren $XXXXXX $CRWV Coreweave $XXXXXX $CIFR Cipher Mining $XXXXXX $WYFI Whitefiber $XXXXXX $GLXY Galaxy Digital $XXXXXX $VST Vistra Corp $XXXXXX $EOSE Eos Energy $XXXXXX $CLS Celestica $XXXXXX $EQIX Equinix $XXXXXX $MU Micron $XXXXXX $VRT Vertiv What would you change or add"
X Link @TacticzH 2025-10-07T19:18Z 28.2K followers, 201.2K engagements
"🚨 $NVO Strategic Move By Novo Nordisk🚨 Novo Nordisk has decided to discontinue its cell therapy research and development efforts. They are laying off nearly all of the divisions' XXX employees. They've been researching this field for about XX years invested billions of dollars but have now decided enough is enough. A spokesperson said: We are in the process of identifying partners with the right capabilities and manufacturing capacity to further develop our innovations. The layoffs are expected to impact studies for an experimental heart-failure stem cell therapy and a Parkinsons disease"
X Link @TacticzH 2025-10-11T08:36Z 28.2K followers, 25.3K engagements
"They say money doesn't grow on trees. But for OpenAI it does. - $300B $ORCL deal - $100B $NVDA deal - $XXXX $CRWV deal - $10B $AVGO deal On top of that they have announced numerous strategic collab deals like the one with $AMD and today's partnership with $AVGO. Projected 2025 revenue for OpenAI =$13B Read that again. REVENUE. $13B. NOT PROFIT Financial engineering at its finest"
X Link @TacticzH 2025-10-13T13:28Z 28.2K followers, 27.2K engagements
"@joecarlsonshow In hindsight this one was so easy. Was looking too cheap for how high quality $ASML is. Getting close to fair value now though"
X Link @TacticzH 2025-10-03T09:37Z 27.9K followers, XXX engagements
"I try to be as transparant and unbiased as possible. Not too long ago I was beating the drum about $ASML as I thought it was heavily undervalued. Now after the recent run-up I think we are approaching fair value. Does that mean we should ignore $ASML now No not at all. But the asymmetric opportunity that I thought it was is not as clear as before. It's still a great company just less attractively valued. Looking at EV/EBIT we are now approach the XX year average same thing applies to other multiples. My approach: I will hold onto my shares for the upcoming 5-10 years. At least that's the"
X Link @TacticzH 2025-10-08T07:29Z 28.3K followers, 25.3K engagements
"Which company do you think is the best buy right now - $UNH at $XXX - $ASML at XXX - $OSCR at $XXXXX - $DLO at $XXXXX - $GRAB at $XXXX - $MELI $2362 - $AMD at $XXX - $HIMS at XXXXX - $ASTS at $XXXXX - $HOOD at $104.85"
X Link @TacticzH 2025-07-27T20:09Z 28.1K followers, 235.4K engagements
"Which stock would you feel comfortable holding for XX years You can not sell For me: $ASML What's your pick"
X Link @TacticzH 2025-05-20T20:15Z 27.9K followers, 30.2K engagements
"@trader_gu @SuEricGP @YodaStockInvest I have no idea what this is mate haha. And im not a trader nor very good at TA"
X Link @TacticzH 2025-10-13T19:40Z 28.2K followers, XXX engagements
"$NVO - One of the largest EPS/Price disconnects I have ever seen"
X Link @TacticzH 2025-10-10T15:21Z 28.3K followers, 175.1K engagements
"My top XX list of wide moat companies: - $ASML ASML Holding N.V. - $V / $MA Visa and Mastercard - $SPGI S&P Global Inc. - $TSCO Tractor Supply Company - $WM Waste Management - $INTU Intuit Inc. - $ISRG Intuitive Surgical - $TSM Taiwan Semiconductor - VIE: $SU Schneider Electric SE - $MSFT Microsoft Corporation Which stocks would you add"
X Link @TacticzH 2025-06-21T20:31Z 28.2K followers, 18.5K engagements
"These XX companies are not a buy right now: - $ASTS - $HIMS - $HOOD - $RKLB - $PLTR - $TSLA - $SOFI - $CRWD - $SPOT - $DUOL All of these companies have had incredible runups but valuations are stretched and a lot of future potential is more than priced in. Will they go up even more Very likely. They have had incredible momentum on their side and markets are still not showing signs of weakness. I simply do NOT like the risk/reward these companies currently provide. And investing for me is also limiting my downside and not chasing the hype. Don't get me wrong some of these companies are great."
X Link @TacticzH 2025-07-12T12:51Z 28K followers, 33.4K engagements
"If I had $100k to spend on a healthcare portfolio it would look like this: $XXXXXX $NVO - Novo Nordisk $XXXXXX $LLY - Eli Lilly $XXXXXX $HIMS - Hims and Hers $XXXXXX $BMY - Bristol-Myers Squibb Co $XXXXXX $JNJ - Johnson & Johnson $XXXXXX $OSCR - Oscar Health $XXXXX $UNH - UnitedHealth Group $XXXXX $TEM - Tempus AI Agree"
X Link @TacticzH 2025-06-13T20:58Z 28.2K followers, 67.1K engagements
"@SoJustFollowMe There's never a rush. But what's your thoughts on them right now Why wait"
X Link @TacticzH 2025-10-14T14:25Z 28.3K followers, 4572 engagements
"@ben_moshenyc Buy-worthy Not so sure about $RACE tbh. That guidance cut was huge"
X Link @TacticzH 2025-10-13T20:17Z 28.2K followers, 1301 engagements
"Post like these are humbling. They make me realize how much more there is to $NBIS than most of us think. How much more there is for me to explore. I also like how McFly addresses uncertainties as there are still many when it comes to execution and in particular the deal with $MSFT. Investing in Nebius is not without risk as many here make you want to believe. Remain critical Good stuff @ilzmcfly"
X Link @TacticzH 2025-10-06T06:52Z 28.2K followers, 10.8K engagements
"🚨 $NVO - Bad News for Novo Nordisk 🚨 Novo's Indiana plant which they recently acquired was hit with FDA's most serious inspection classification portending possible delays for Novo and partners. The FDA has tagged the former Catalent facility with an official action indicated (OAI) label which is the most severe of the three inspection classifications issued by the agency. There are issues regarding quality control and hygiene Similar issues and warnings were already handed out during the summer and have apparently not yet been resolved. Companies like $REGN and $SRRK are also impacted as"
X Link @TacticzH 2025-10-14T08:16Z 28.2K followers, 42.8K engagements
"All of this will be impossible without $ASML and $TSM"
X Link @TacticzH 2025-10-10T12:22Z 28.2K followers, 8620 engagements
"4.1/ Current portfolio and products $NVO has a wide range of different drugs mostly focused on insuline and obesity. Here are the most important ones: - Ozempic (diabetes but used for weight loss too) - Wegovy (basically Ozempic but aimed at obesity) - Rybelsus (current oral version of Semaglutide) - Oral Wegovy (new oral version of Semaglutide) - Victoza and Saxenda (injectables based on Liraglutide Both Ozempic and Wegovy are what we call GLP-1 drugs and both have the active ingredient Semaglutide. A GLP-1 drug is a medicine that mimics or enhances the action of glucagon-like peptide-1"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 2087 engagements
"8.2/ Risk and headwinds: Stagnant demand The main risks for Novo Nordisk right now are stagnant demand combined with increasing competitive pressure: demand for Wegovy for weight loss in the U.S. has not picked up since mid-February. At the same time Eli Lilly is aggressively pushing into the market with Zepbound. The constant pressure of both Eli Lilly and compounders is providing Novo with serious growth problems right now. Capacity restraints Capacity restraints are also still troubling but should be resolved on a relatively short basis as the current heavy capex investments should relieve"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 1350 engagements
"$DLO Dlocal Q2 - Earnings review The stock went flying after they significantly beat estimates and raised their guidance. The stock is up XX% since. Here is an overview of why: 🧵"
X Link @TacticzH 2025-08-15T10:09Z 28.2K followers, 18.1K engagements
"@meeijer Valuation"
X Link @TacticzH 2025-10-13T20:17Z 28.2K followers, 3917 engagements
"$NVO - What TrumpRX means for Novo Nordisk Yesterday Trump announced TrumpRX (this dude and his own name). It's basically a DTC-website for ''discounted drugs''. Part of the announcement was a deal with Pfizer which voluntarily agreed to lower prices. TrumpRX is set to go live in early 2026. Here are my thoughts as to what this means for no $NVO: I think it basically means two things: X It pressures Novo to lower prices X It's a possible new avenue for direct-to-consumer sales I think the likelihood of Novo participating in TrumpRX is very high. Novo Nordisk is already offering Ozempic"
X Link @TacticzH 2025-10-01T08:09Z 28K followers, 19.6K engagements
"$NVO - I'm getting some questions as to why this deal with Akero $AKRO is not very well received (initially). I still have to learn more but I think the bad reaction stems from: ✅ It's just another acquisition that will sit in the way of buybacks ✅ Novo pays a XX% premium for the company ✅ Akero's EFX is still in phase X ✅ While it compliments their overall portfolio it is not specifically ''obesity''-focused. Those are just my first thoughts. Personally I'm not really against or for this acquisition. This is not what will drive Novo's share price significantly up or down"
X Link @TacticzH 2025-10-09T11:02Z 28.2K followers, 18.6K engagements
"In the near term it might certainly feel that way. But valuation has come down significantly so a lot of the pain is already reflected in the price imho. Investing in $NVO should be a long-term bet not a quick win. This might hurt for a bit. But they're still positioned extremely well to be a great beneficiary of the long-term obesity treatment tailwinds"
X Link @TacticzH 2025-10-07T11:28Z 28.1K followers, 1459 engagements
"12/ Valuation Novo currently generates about $14.6B of net income on $42.1B in revenue. Lets assume net income continues to compound at a XX% CAGR. ✅When we apply a XX PE to it: we get total market cap of $576B. ✅When we apply a XX PE to it: we get a MC of $432B The current market cap is $271.64B. That would mean: ✅Valuation at XX P/E: $576B CAGR XXXX% ✅Valuation at XX P/E: $432B CAGR XXX% EPS Calculator I used the basic DCF calculator in Qualtrim to make some basic assumptions on the potential of $NVO. Keep in mind that this is an oversimplified way of looking at valuation but it still"
X Link @TacticzH 2025-10-03T14:47Z 28.2K followers, 1111 engagements
"$NVDA CEO Jensen Huang sees a massive $3T-$4T AI infra spending by 2030. To him this AI boom is only getting started. Here are my XX favorite picks to benefit from this AI transition that is still in it's early stages 👇 🧵 1/ $NVDA Nvidia The most obvious bet right now is of course Nvidia. Their GPUs are essential to the potential explosion and growth of AI and AGI. Their GPUs are the de facto standard for training and running complex AI models. They have an estimated 90%+ market share in the data center AI chip market. This means any company building or deploying a large-scale AI system"
X Link @TacticzH 2025-08-29T13:04Z 28.3K followers, 372.1K engagements
"@dividendology Great post and good breakfown of $SPGI. It is one of my favourite companies and yet my position is not yet as big as I want it to be. It's getting to the point I can finally increase it"
X Link @TacticzH 2025-10-05T18:25Z 28.3K followers, 1420 engagements
"$NBIS with another all-time high today. I expected a lot when I opened my position in $NBIS in January but I did not expect to be up XXX% this year (even with some trimming along the way). Overvalued or still more upside"
X Link @TacticzH 2025-10-09T20:32Z 28.2K followers, 29.9K engagements
"Important note on the $NVO acquirement of $AKRO: ✅No change to 2025 operating profit outlook but free cash flow to decline by about USD X billion implying X to XX billion DKK depending on closing timing. ❌2026 operating profit growth expected to drop by around X percentage points due to higher R&D spending. 👉Acquisition will be primarily financed through debt"
X Link @TacticzH 2025-10-09T12:02Z 28.2K followers, 8128 engagements
"10.4/ ROIC and ROCE All this capex spending might be worrisome to some but remember Novo has always been an excellent capital allocator. And their ROIC and ROCE show this. Novo Nordisk has delivered exceptional returns on invested capital (ROIC). Over the last few years ROIC has ranged from XX% to XX% vastly exceeding its cost of capital. Such high ROIC reflects managements disciplined investment strategy. - ROIC: XXXX% - ROCE: 65.2%"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 1173 engagements
"🚨 $NVO Novo starts cutting jobs in the US 🚨 Novo has decided to cut jobs at their largest US manufacturing plant Clayton. We are talking about ''dozens'' of employees here ranging in jobs like quality control line technicians and HR staff. So job cuts along the line. As many of you know this is part of a broader global restructuring plan in which they will cut 9000 roles of which 5000 are planned in Denmark alone. It's a clear sign that Novo is ready to start executing the announced lay-offs and it will hopefully enhance the balance between cost control and future growth. I don't see this"
X Link @TacticzH 2025-10-07T11:14Z 28.2K followers, 14.7K engagements
"Which pair do you think will perform the best over a X year period X. $ASML/ $TSM X. $NBIS/ $IREN X. $NVDA / $AMD 4/ $SE / $MELI 5/ $NVO / $LLY 6/ $OSCR / $UNH 7/ $DLO / $ADYEN 8/ $BABA / $PDD X. $SPGI/ $MCO XX. $V/ $MA"
X Link @TacticzH 2025-09-18T17:55Z 28K followers, 76K engagements
"6/ $LLY Eli Lilly is a global pharmaceutical company. They discover develop manufacture and sell prescription medications for a range of conditions but have a strong focus on diabetes and obesity. They also focus on cancer immunology neuroscience and Alzheimers. They're bestknown for their GLP1 drugs: Mounjaro (for type X diabetes) and Zepbound (for obesity) which propelled revenue growth and helped Lilly become one of the most valuable drugmakers ever. Right now Lilly is boosting manufacturing improving drug access via its LillyDirect platform and pushing forward on pipeline assets like"
X Link @TacticzH 2025-07-20T13:41Z 27.9K followers, 3563 engagements
"2.1/ Company overview - The Foundation When investing in Novo its important to understand the companys corporate structure. At the top you have the Novo Nordisk Foundation. A non-profit organization focused on ensuring the long-term succes of Novo Nordisk and supporting scientific research and humanitarian causes. The Foundation owns Novo Holdings A/S. Think of Novo Holdings as the investment manager for the Foundation. The foundation also owns Novonesis (the result of Novozymes merging with Chr. Hansen). Novonesis develops biosolutions. Novo Nordisk A/S is the company youd be investing in if"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 2460 engagements
"My latest buys and sells: Buy: - $DLO - $OSCR - $BABA Sell: - $VST - $AXON What are yours"
X Link @TacticzH 2025-07-11T08:49Z 28.3K followers, 23.8K engagements
"1/ Origin story What started as an insulin manufacturer turned out to be one of the global leaders in the diabetes and obesity sector. Novo Nordisks roots go back to the early 20th century in Denmark when two rival companies Novo Terapeutisk Laboratorium (founded in 1925) and Nordisk Insulinlaboratorium (founded in 1923) were among the first outside Canada to produce insulin after its discovery. For decades they competed with each other while also pioneering diabetes care. By the early 1970s both companies had established themselves internationally and in 1974 Novo launched an IPO on the"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 2579 engagements
"7/ $PME Pro Medicus is an Aussie health-tech company that builds slick medical imaging software. Hospitals and imaging centers across Australia North America and Europe use its Visage platforms to view and manage CT MRI PET scans in 2D 3D even 4D making radiology workflows smoother and faster In a nutshell: PME is the behind-the-scenes imaging tech that helps doctors see clearly and its cashing in on global hospital digital upgrades. ✅5 Year Revenue CAGR: XXXX% ✅ X Year EPS CAGR: XXXX% For the next X years expectations are: ✅EPS: XXXX% ✅Revenue: 34%"
X Link @TacticzH 2025-07-20T13:41Z 28.3K followers, 3237 engagements
"@meeijer Out of these I would only buy $NVO right now. $DLO is getting close as well. This week im also checking out $INT (Intellego) as it's falling from grace"
X Link @TacticzH 2025-10-08T20:17Z 28.2K followers, 9983 engagements
"@KaramDhanoa1 They did release 2026 guidance: ''not lower than 2025''. But I'd of course love more details there haha. They have more customers than China but it will be tricky if they can compensate the loss of sales there"
X Link @TacticzH 2025-10-15T11:41Z 28.3K followers, XX engagements
"5 stocks I consider buy-worthy today: - $DLO DLocal - $NVO Novo Nordisk - $AMZN Amazon - $EVO Evolution AB - $DAVE Dave X stocks I would ignore: - $PLTR Palantir - $OKLO Oklo - $TSLA Tesla - $ASTS AST SpaceMobile - $HIMS Hims & Hers X stocks high on my watchlist: - $BN Brookfield Corp - $FFX Fairfax Financial Holdings - $CSU Constellation Software - $SE Sea ltd - $AXON Axon Agree"
X Link @TacticzH 2025-10-13T20:15Z 28.3K followers, 84.5K engagements
"@HatedMoats What company will you be covering next Mate And thanks for sharing my deep dive"
X Link @TacticzH 2025-10-13T20:00Z 28.2K followers, XXX engagements
"These TEN companies are high on my watchlist and they should be on yours too. My thoughts + buy levels for all of them. Which companies should I add to this watchlist 🧵👇 1/ $AMD Advanced Micro Devices Last year I researched both $NVDA and $AMD and I went with $NVDA as they are still clearly the market leader. And that's what I usually go with. However after doing more research I now think the best bet is to own both of them. The TAM is big enough and they can easily co-exist. $AMD keeps taking share from $INTC with superior CPUs they are now a strong alternative to $NVDA in AI with its"
X Link @TacticzH 2025-08-24T14:22Z 28.2K followers, 87.3K engagements
"4/ $SE Sea Limited I also try to look outside the US for great companies. The next X on this list are among the best to me. Sea limited is often called the ''Amazon of Southeast Asia'' and for good reason. Sea Limited's Shopee platform is the leading e-commerce marketplace in Southeast Asia. On top of that you have Garena (gaming platform) and SeaMoney ( mobile wallet payments and digital lending. Growth has been really strong in the last X years growing at XX% CAGR. In 2023 they turned profitable which was a huge step for them. This one sits high on my watchlist but I would need a lower"
X Link @TacticzH 2025-08-24T14:22Z 28.3K followers, 6839 engagements
"You have to stay humble while investing. There is always something else to learn"
X Link @TacticzH 2025-10-12T07:49Z 28.2K followers, 197.5K engagements
"Here are XX great stocks from emerging markets worth looking into if you want to diversify: $CPNG Coupang $SE Sea Limited $NU Nu Holdings Ltd. $MELI MercadoLibre Inc. $BABA Alibaba Group Holding Limited $JD Inc. $DLO DLocal Limited $XIAOMI Xiaomi Corporation $GRAB Grab Holdings Inc. $SGML Sigma Lithium Corporation $BYD BYD Company Limited $TATAMOTORS Tata Motors Limited $TM Toyota Motor Corporation Which is your favorite"
X Link @TacticzH 2025-06-09T18:19Z 28K followers, 35.7K engagements
"Which company do you think is the best buy right now - $NVO at $XX - $UNH at $XXX - $ASML at XXX - $GOOGL at $XXX - $SOFI at $XX - $SPOT at $XXX - $FICO at $1381 - $RKLB at $XX - $ZETA at $XX - $TSLA at $302"
X Link @TacticzH 2025-08-03T20:19Z 28.2K followers, 326.9K engagements
"6/ $CORZ Core Scientific Core Scientific once a major Bitcoin miner has transformed into a provider of AI-ready digital infrastructure. Its purpose-built data centers deliver over XXX GW of power and advanced cooling to support the massive demands of AI chips and servers. Riding the AI infrastructure shortage Core Scientific secured multi-billion-dollar long-term contracts with partners like $CRWV. The demand surge also led to its $9B all-stock acquisition by CoreWeave giving shareholders exposure to a combined entity poised to scale with the AI CAPEX boom"
X Link @TacticzH 2025-09-09T17:27Z 28.2K followers, 7299 engagements
"13/ Summary Investing in $NVO or any healthcare company for that matter does not come without risks. As I discussed a lot of the drawdown we have seen for Novo is fully justified. The company is facing serious headwinds and risks and will have to execute well to come back out on top. With the new management changes and the strong pipeline I think a turnaround is definitely possible. Looking ahead I think CagriSema and Amycretin are two excellent growth drivers with huge potential. But the biggest potential remains in the oral GLP-1 battle. Oral Wegovy is the ace in the hole. They have"
X Link @TacticzH 2025-10-03T14:47Z 28.2K followers, 3044 engagements
"@Ashton_1nvests $NVO and $DLO still look great here"
X Link @TacticzH 2025-10-08T20:12Z 28.1K followers, XXX engagements
"I'm going to make a new thread on companies that dropped significantly since their latest earnings. My short-list now is: $TTD $DAVE $RACE $LLY $FICO $SMCI $GRAB $PYPL $FTNT Which other companies should be on the list"
X Link @TacticzH 2025-08-11T07:35Z 28.2K followers, 55.9K engagements
"10.2/ Free Cash Flow Novo has always had a strong balance sheet. However in the last X years FCF has declined. This is mostly due to increased capex requirements and spend. After their capex spending spree this is very likely to increase again as these forecasts show. If margins can stabilize and CAPEX spend declines FCF is expected to start increasing from 2026 onwards"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 1189 engagements
"3/ Management $NVO has been around for over XXX years and it that time theyve only had X CEOs (the 6th one was added this August (in 2025). That speaks volumes. Novo has always been focused on the long-term and their CEOs reflect that. The average CEO holds the position for just under XX years and therefore the replacement of Lars Fruergaard Jrgensen came as a surprise to most. He was recently replaced by (another company insider) Mike Doustdar. On a first glance he seems to be ready to make big decisions. He got handed the company in pretty bad weather but it seems hes holding up a nice big"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 2244 engagements
"@InvestingVisual What the hell. Rate earth is the new AI Where are most of these from China"
X Link @TacticzH 2025-10-13T20:05Z 28.2K followers, 2606 engagements
"Which of these currently ''unloved'' stocks is not a value trap right now - $NVO at $XXXXX - $ADBE at $34870 - $MRVL at $XXXXX - $TTD at $XXXXX - $CRM at $XXXXXX - $DUOl at XXXXXX - $ENPH at $3763 - $LULU at $15963 - $LVMH at XXX - $FICO at $1544"
X Link @TacticzH 2025-09-14T19:24Z 28K followers, 50.9K engagements
"5/ $DECK Deckers Outdoor is down almost XX% YTD. Like many retailers they are not in a great spot. They are facing slowing growth for its key brands Hoka and UGG and have warned of a tough consumer spending environment. Inventory levels are high and the impact of new tariffs on the products are squeezing margins. It's not all bad: Deckers has a strong balance sheet with no debt and is actively using its cash to buy back shares. The latest earnings report showed improved international growth and analysts have been raising price targets. The core brands have proven to be resilient. Valuation is"
X Link @TacticzH 2025-07-31T15:02Z 28.2K followers, 7407 engagements
"Is this the best risk/reward play right now $NVO"
X Link @TacticzH 2025-09-25T20:00Z 28.2K followers, 95.1K engagements
"10.1/ Revenue Revenue has been steadily compounding at a CAGR of XXXX% since 2016. However since the introduction of the GLP-1s this growth rate accelerated in the last X years. Revenue grew at a CAGR of XX% in the last X years and a CAGR of XXXX% in the last X years. Revenue forecasts for the next X years average between X% and 9%. The majority of Novos revenue comes from the US. This is also why it remains so important for Novo to keep being competitive in the US. Any large policy changes and/or tariffs will cut into their overall revenue like butter. Keeping up with Eli Lilly is vital"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 1329 engagements
"$100k to spend and looking for a turnaround centered portfolio Here's how I'd do it: $XXXXXX $EVO Evolution AB $XXXXXX $NKE Nike $XXXXXX $PEP PepsiCo $XXXXXX $ENPH Enphase $XXXXXX $BLDR Builders Firstsource $XXXXXX $INTC Intel $XXXXXX $MC LVMH $XXXXX $UNH United Health Group Agree Disclaimer I only hold $EVO $BLDR and $MC"
X Link @TacticzH 2025-06-14T20:04Z 28.1K followers, 19K engagements
"I sold my full $OSCR position today. I took a good hard look in the mirror and realized I just don't understand the company well enough. Took a nice XX% gain and will see later what I'll do with the cash. I just posted an update on my SS with more reasoning behind this decision. I post all my buys/sells and portfolio updates there. Link in bio and in the comments below. Am I an idiot or reasonable move"
X Link @TacticzH 2025-10-09T13:48Z 28.3K followers, 131.7K engagements
"Looking to diversify away from the US stock market This is the only watchlist you need: $SIE Siemens AG $TSM Taiwan Semiconductor $IREN Iren Ltd $PDD Pinduoduo $SPOT Spotify Technology S.A. $BN Brookfield Corporation $RHM Rheinmetall $KPG Kelly Partners Group $CSU Constellation Software $CDLR Cadeler A/S $VLK Van Lanschot Kempen N.V. $MELI MercadoLibre $XIAOMI Xiaomi Corporation $RMS Hermes International SCA $EVO Evolution AB $ADYEN Adyen $NVO Novo Nordisk $RYCEY Rolls Rocye $CPNG Coupang $LDO Leonadro SpA $SE Sea Ltd $TOI Topicus Inc. $BABA Alibaba $LVMH LVMH Mot Hennessy Louis Vuitton SE"
X Link @TacticzH 2025-08-19T07:49Z 28.2K followers, 52.6K engagements
"@DeepIceValue It's not the same $ASML maintained their 2030 targets/range. They were just unclear about the short-term $RACE cut their guidance all the way up to 2030"
X Link @TacticzH 2025-10-14T14:35Z 28.2K followers, XXX engagements
"5/ $MELI MercadoLibre The second strong non-US company is Mercadolibre. Just like Sea Limited growth has been incredible these past years. They too have been called the Amazon + PayPal + eBay of Latin America. $MELI is the largest e-commerce and fintech ecosystem in Latin America and they really have been dominating these last couple of years. Growth was above XX% CAGR in the past X years and for the next two years XX% CAGR is expected. $MELI is perfectly set-up to benefit from massive EM tailwinds like the growing middle class retail e-commerce boom and fast-growing digital payments. My buy"
X Link @TacticzH 2025-08-24T14:22Z 28.3K followers, 5926 engagements
"🚨Just in - $DLO - Dlocal🚨 DLocal and Western Union today announced a strategic partnership to enable digital payment methods on Western Unions online platforms in Latin America. The agreement between will enhance the remittance experience in Latin America by integrating local and alternative payment methods into Western Unions digital channels. Customers in countries like Chile Mexico Peru Panama Argentina and Brazil will gain greater flexibility and control over their transfers with potential expansion to other markets. The partnership also supports the growth of the regions digital"
X Link @TacticzH 2025-09-09T12:22Z 28.2K followers, 7334 engagements
"$NBIS - All current Price Targets. - Northland Securities: $XXX - Goldman Sachs: $XXX - Arete: $XXX - D.A Davidson: $XXX - BWS: $XXX - HedgeEye: Long = Seaport Global: Neutral Nebius currect price is: $XXXXXX All price targets were updated in the September. Which price target do you agree with most"
X Link @TacticzH 2025-10-05T12:29Z 28.2K followers, 33.4K engagements
"If I had $100k to build a grow stock portfolio it would look like this: $25k - $NBIS Nebius Group $25k - $HIMS Hims and Hers $15k - $AXON Axon Enterprise $15k - $NU Nu Holdings $10k - $HOOD Robinhood $10k - $SOFI Sofi Technologies. Agree"
X Link @TacticzH 2025-05-10T18:33Z 27.9K followers, 78.6K engagements
"5/ $CSU Constellation software Constellation Software acquires manages and grows vertical market software companies. These are specialized software businesses that serve specific industries like healthcare finance public transit and more. CSU focuses on buying small to mid-sized companies with strong customer relationships and predictable revenues. Most of their businesses sell mission-critical software on a subscription basis leading to high recurring revenue and stability. They have delivered exceptional shareholder returns in the last decade and I expect them to continue doing so. They are"
X Link @TacticzH 2025-07-14T20:24Z 27.9K followers, 5866 engagements
"🚨JUST IN - $NVO - Novo Nordisk about to cut 9000 roles🚨 But the big thing. They even further lowered their operating profit growth outlook to 4-10&. (this was already lowered to 10-16% earlier this year. Novo Nordisk announced a major restructuring to streamline operations speed up decision-making and focus resources on growth in diabetes and obesity. The plan includes cutting about 9000 jobs globally (5000 in Denmark) from its 78400 workforce. The move responds to rising demand growing competition in obesity treatments and rising complexity from rapid scaling. $NVO aims to reinvest savings"
X Link @TacticzH 2025-09-10T05:29Z 28.2K followers, 125.6K engagements
"Here are my XX favorite NON-US companies You should be watching these 🧵 1/ $NBIS Nebius is highly specialized in AI-centric cloud infrastructure and services. When you buy Nebius you buy a stake in: ✅Nebius core: AI-centered cloud platform + data centers ✅Avride: Autonomous driving and delivery robots ✅Clickhouse: open-sourced column-oriented SQL database management system ✅TripleTen: Online education platform that provides coding bootcamps ✅Toloka: Crowdsourcing platform that provides human-annotated data for training and evaluating AI models All of these together make them a very strong AI"
X Link @TacticzH 2025-07-11T20:37Z 27.9K followers, 56.2K engagements
"''Always one tweet away from a bad day'' Today is just another reminder that as long as the Orange man is running the world you can't take anything for granted. This is also why it's smart to take some profits on the way up and why you should be very careful when taking leverage. This -XXX% little mini-dip is nothing in the grand scheme of things. I know that. But when China and the US start going head-to-head again things might get a lot more ugly really fast. I'm sitting on XX% cash right now after I sold my $OSCR position this week. I'm gonna keep an eye out for some good opportunities in"
X Link @TacticzH 2025-10-10T20:43Z 28.3K followers, 12.2K engagements
"@DeepIceValue Nice I like that $SPGI pick up"
X Link @TacticzH 2025-10-03T10:49Z 28K followers, XXX engagements
"Here are my top XX plays with exposure to nuclear energy: - $VST Vistra Corp - $RR Rolls Royce - $LMT Lockheed Martin - $CEG Constellation Energy - $OKLO Oklo - $HON Honeywell - $D Dominion Energy - $CCJ Cameco - $GEV GE Vernova - $BWX BWX Technologies Which is your favorite Why nuclear stocks The energy consumption of data centers is projected to DOUBLE or even TRIPLE in the coming years. Some estimates suggest that by 2030 electricity used by data centers alone could be comparable to that of entire countries like India or Germany. We WILL need NUCLEAR power to meet those incredibly high"
X Link @TacticzH 2025-06-20T18:45Z 28.1K followers, 19.5K engagements
"6/ $NU $NU is a digital financial services platform primarily operating in Brazil Mexico and Colombia. They offer a wide range of financial products and services through its mobile platform including credit and debit cards digital bank accounts personal loans investment products (NuInvest) and insurance solutions (NuInsurance). $NU is there to take over where traditional banks failed. And they've been crushing it 👇 Growth 5Y - Rev: XXXX% - EPS: XXXX% - Revenue growth next X year: XXXX% Operational - ROIC: XXX% - Gross margin: XXXXX% Valuation - Forward PE: XXXX - PEG: X - P/OCF: 37.52"
X Link @TacticzH 2025-07-11T20:37Z 28K followers, 3907 engagements
"In my full deep dive which I posted on SS I cover all these drugs and their usecases more in-depth. Also compare them to $LLY The full almost 10k words article can be found for free right here: Make sure to subscribe if you like it. My next deep dive will be on $ASML"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 1756 engagements
"8/ $CEG Constellation Energy Constellation Energy is the largest U.S. producer of carbon-nautral energy powered mainly by its nuclear fleet alongside hydro wind and solar assets. It supplies reliable electricity to homes businesses governments and a large share of Fortune XXX companies. AI data centers need round-the-clock uninterrupted power making Constellations nuclear plants a perfect fit. Long-term PPAs like its 20-year deal with $MSFT secure predictable revenue while funding plant upgrades. The market now views Constellation as a critical AI infrastructure provider driving a premium"
X Link @TacticzH 2025-09-09T17:27Z 27.9K followers, 7045 engagements
"3/ $CSU Constellation Software Constellation software is one of the best compounders in the market. They are basically a holding company that acquires owns and operates vertical market software (VMS) businesses. And they do it very well. They've grown to be a decentralized empire of niche software companies grown by systematically acquiring sticky cash-generating businesses and compounding returns over decades. They've grown their revenue at XX% CAGR in the last XX years and they continue to compound. One of the best capital allocators in the world. My buy level: 3900CAD"
X Link @TacticzH 2025-08-24T14:22Z 28.3K followers, 6708 engagements
"🚨 $NVO $LLY - Good news for GLP-1s 🚨 Novo's Wegovy and Lillys Zepbound are now recommended in Europe as first-line obesity treatments. The European Association for the Study of Obesity (EASO) announced a new framework recommending that Novo's Semaglutide (Wegovy) and Lilly's Tirzepatide (Zepbound) should be the FIRST-LINE treatment options for obesity and related complications. This coincides with a study published in Nature Medicine which evaluated the impact of various obesity therapies. The study emphasizes that due to their high effectiveness Semaglutide and Tirzepatide should be the"
X Link @TacticzH 2025-10-02T13:05Z 28.1K followers, 12.3K engagements
"Top European Quality Companies 💎 X. $ASML ASML X. $RMS Hermes X. $ADYEN Adyen X. $NVO Novo Nordisk X. $SIE Siemens AG X. $SE Schneider Electric X. $EVO Evolution AB X. $RACE Ferrari X. $INVE-B Investor AB XX. $WKL Wolters Kluwer XX. $MC / $LVMH Louis Vuittion Mot etc. XX. $OR L'oreal SA XX. $CHEMM ChemoMetec Agree Which would you add"
X Link @TacticzH 2025-05-21T07:39Z 28.2K followers, 47.9K engagements
"$ASML - UBS raises price target to XXX UBS raised its price target on ASML to XXX from XXXXXX last Wednesday while maintaining a Buy rating Main reasons: - Revised EPS estimates: 15-10% for 2026-2027 driven by AI-led memory growth and better-than-expected smartphone and PC sales as key drivers. - UBS expects favorable newsflow for ASML over the next 6-12 months particularly regarding high-NA opportunities"
X Link @TacticzH 2025-10-03T07:04Z 27.9K followers, 14.6K engagements
"This is my perfect $100K non-US portfolio: - $XXXXXX $CSU - Constellation Software - $XXXXXX $ASML - ASML - $XXXXXX $SPOT - Spotify - $XXXXXX $SE - Sea Ltd - $XXXXXX $DLO - DLocal - $XXXXXX $NBIS - Nebius - $XXXXXX $MELI - MercadoLibre - $XXXXXX $NVO - Novo Nordisk - $XXXXXX $TSM - Taiwan Semi What would you change or add"
X Link @TacticzH 2025-07-08T20:13Z 28.1K followers, 34.9K engagements
"ROAST MY PORTFOLIO DO NOT HOLD BACK What would you change/add/remove"
X Link @TacticzH 2025-09-17T19:58Z 28.2K followers, 140.3K engagements
"After the great support I received on my $NVO Deep Dive I'm now working on a big $ASML Deep Dive. I hope to finish it within the next week ASML reports earnings this Wednesday so I will include this earnings report in my analysis and also run the (new) numbers in my valuation model. Are you interested Be sure to subscribe to my SS as that will be where I will post it (and a lot of other things too). 📎Link in my bio and in the comment section below"
X Link @TacticzH 2025-10-13T08:43Z 28.2K followers, 40.9K engagements
"Are $NVDA $AMD $ORCL and OpenAI inflating the market My spidey senses are tingling Billions are poured into the market. But the money doesnt seem to leave the closed ecosystem these companies operate in. NVIDIA is investing up to $100B in OpenAI which in turn must spend that capital buying NVIDIA chips. Good deal for all right $ORCL also signed a record $300B cloud agreement to host OpenAIs data centers while also spending tens of billions on GPUs for those same facilities. Everyone happy And today OpenAI and $AMD have signed a supply partnership potentially worth billions of dollars. Is this"
X Link @TacticzH 2025-10-06T14:40Z 28.3K followers, 6613 engagements
"8.1 / Risks and headwinds - Guidance cuts Right now we first have to get through the weaker growth. Novo Nordisk has cut its 2025 guidance multiple times with the latest cuts in September 2025 reducing operating profit growth to 4%10% due to significant costs associated with a workforce reduction. This follows an earlier cut in July 2025 which had lowered the full-year sales growth forecast to 8%14%. Personally Im ok with this Im not investing to cash out in 2025 or 2026 this is a multi-year bet on a potential strong turnaround play"
X Link @TacticzH 2025-10-03T14:46Z 28.1K followers, 1370 engagements
"One of the strengths of $DLO Dlocal -- its ability to grow revenue from its existing customer base. This demonstrates that Dlocal's product is providing value to its customers who are not only sticking around but also expanding their business. This shows strong customer loyalty and a healthy business model. DLocal has consistently reported very high NRR rates often significantly above XXX% albeit in a downtrend over the last years. However that downtrend was broken since June last year and we are back to XXX% now"
X Link @TacticzH 2025-09-03T08:38Z 28.2K followers, 5450 engagements
"$NVO - ''A BET ON THE FAT'' - Full thesis 🧵 Novo Nordisk is still unloved and unwanted. That's exactly when we should dive deeper. Find below my full deep dive on this (in my opinion) fantastic asymmetric opportunity. A big thread 👇"
X Link @TacticzH 2025-10-03T14:46Z 28.2K followers, 45K engagements
"@TheEUInvestor Not clear to me at this stage. But the article stated telehealth platforms ''such'' as Ro And WW. So they'll likely include others as well i'd assume"
X Link @TacticzH 2025-10-04T08:37Z 27.8K followers, 1886 engagements
"Reduced my $NBIS position from XX% tot 9%. Initial amount I put in is now secured. Plan on letting it run from here on out ( or add when it turns to undervalued again) I still really like the company and it's growth prospects but I think the risk/reward is less favorable than it was a couple months ago. Just to be clear: it's still my 2nd largest holding. I'm not bearish"
X Link @TacticzH 2025-10-02T14:34Z 27.9K followers, 15.3K engagements
"@InvestingVisual What I'd like to see from $ASML: - Earnings report on time not a day early. - Guidance for 2026. That's all"
X Link @TacticzH 2025-10-13T20:05Z 28.2K followers, 1582 engagements
"$BLDR - TOP XX performer in the S&P500 in the last X and XX years but still quite unknown. My thoughts on BUILDERS FIRSTSOURCE 🧵 1/ Company overview Imagine you want to build a house add an extension or do a big renovation. You're going to need a lot of materials. Things like wood for the frame pre-built sections like wall frames or roof pieces windows doors and all sorts of other supplies. Builders FirstSource is essentially a giant supplier for people who do this kind of work professionally like home builders and remodeling companies. Think of them like a massive hardware store or a"
X Link @TacticzH 2025-05-17T11:04Z 28.2K followers, 30K engagements
"With US-markets touching all-time highs I'm more and more looking to diversify and buy Non-US companies. Here are my top XX picks outside of the US. - $SE Sea Limited - $CPNG Coupang - $DLO dLocal - $TSM Taiwan Semiconductor - $ASML ASML - $BABA Alibaba - $MC / $LVMH LVMH - $GRAB Grab - $MELI Mercadolibre - $NU Nu Holdings I currently own shares in $DLO $TSM $ASML $BABA and $LVMH. But I really like what I see in the other companies as well. Which one is your favorite"
X Link @TacticzH 2025-06-27T07:54Z 28K followers, 30.8K engagements
"🚨 $NVO - Big Move by Novo Nordisk 🚨 Novo Nordisk plans to launch its new obesity pill via telehealth to regain market share. Yesterday Novo's US COO confirmed that Novo plans to launch ''Oral Wegovy'' via telehealth platform likes RO and Weightwatchers. This is on top of distribution through it's own DTC-platform Novocare. The aim is to make the new pill easily accessible to everyone and also cut out the need for insurance coverage. The battle for ORAL GLP-1 market-share is only getting started. They might also introduce a subscription-based model where patients could sign up for six to 12"
X Link @TacticzH 2025-10-04T08:27Z 28.2K followers, 71.9K engagements